High throughput screening for drugs that inhibit 3C-like protease in SARS-CoV-2

The SARS coronavirus 2 (SARS-CoV-2) pandemic remains a major problem in many parts of the world and infection rates remain at extremely high levels. This high prevalence drives the continued emergence of new variants, and possibly ones that are more vaccine-resistant and that can drive infections ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Emery, Davis-Gardner, Meredith E., Garcia-Ordonez, Ruben D., Nguyen, Tu-Trinh, Hull, Mitchell, Chen, Emily, Yu, Xuerong, Bannister, Thomas D., Baillargeon, Pierre, Scampavia, Louis, Griffin, Patrick, Farzan, Michael, Spicer, Timothy P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. on behalf of Society for Laboratory Automation and Screening. 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9839384/
https://www.ncbi.nlm.nih.gov/pubmed/36646172
http://dx.doi.org/10.1016/j.slasd.2023.01.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9839384/
https://www.ncbi.nlm.nih.gov/pubmed/36646172
http://dx.doi.org/10.1016/j.slasd.2023.01.001

Ejemplares similares